Sanofi
Membre du Pacte mondial de l'ONU
Siège France
Sanofi-Aventis website / Site web de Sanofi-Aventis (français)
Sanofi was known as Sanofi-Aventis from its merger with Aventis in 2004 until May 2011.
Souscrire au flux RSS de cette rubrique
Toutes les histoires
Auteur: [opinion] Philip Stevens, International Policy Network, in Nation [Thailand]
The government has just broken the patents on two more drugs [Kaletra by Abbott Laboratories, Plavix by Sanofi-Aventis & Bristol-Myers Squibb] and is on the verge of breaking 11 more, loudly applauded by international activists... It claims the...
- Egalement dans: Abbott Labs offers lower price on AIDS drug Kaletra to Thailand after Govt. threatens to issue compulsory licence
- Entreprises concernées: Abbott Laboratories Bristol-Myers Squibb Sanofi
Auteur: Nopporn Wong-Anan, Reuters
Thailand, which has upset big drug companies by issuing patent-overriding licences for generic versions of heart and HIV/AIDS pills, said on Monday it would issue more unless the firms cut prices... Last week, the Health Ministry issued compulsory...
- Egalement dans: Abbott Labs offers lower price on AIDS drug Kaletra to Thailand after Govt. threatens to issue compulsory licence
- Entreprises concernées: Abbott Laboratories Bristol-Myers Squibb Genentech Sanofi
La Thaïlande ose les génériques
Auteur: Philippe Rivière, Le Monde Diplomatique
le 30 janvier, le ministre de la santé, M. Mongkol na Songkla, a signé le décret qui lui permet de prendre des licences obligatoires sur le Kaletra (un traitement anti-VIH) du laboratoire américain Abbot et le Plavix, un anticoagulant du laboratoire...
- Egalement dans: Abbott Labs offers lower price on AIDS drug Kaletra to Thailand after Govt. threatens to issue compulsory licence
- Entreprises concernées: Abbott Laboratories Hetero Merck Ranbaxy Laboratories Sanofi-Aventis
Auteur: AP
Thailand's decision to break the patents on two major commercial drugs to allow the sale of cheaper generic versions was applauded Tuesday by health activists but questioned by the pharmaceutical industry. On Monday, Thai Public Health Minister...
Auteur: Pongpiphat Banchanont, Reuters
Thailand's army-appointed government confirmed on Monday it approved a cheap, copycat version of a blockbuster heart disease drug, the first time a developing country has torn up the international patent for such a treatment. In addition to the ...
- Entreprises concernées: Abbott Laboratories Bristol-Myers Squibb Merck Sanofi
Auteur: Nopporn Wong-Anan, Scientific American
Thailand's army-installed government has issued licenses for cheap generic versions of a heart disease and an AIDS drug...Drug companies reacted angrily to the announcement…and urged [the health minister] to reconsider a decision they said could lead...
- Entreprises concernées: Abbott Laboratories Bristol-Myers Squibb Merck Sanofi
Rapport de responsabilité sociale des Entreprises du Médicament - engagements dans l’accès aux soins & médicaments, l’impact environnement, dialogue avec les parties prenantes
[PDF] Responsabilité sociale des Entreprises du Médicament - Rapport 2006
Auteur: Les Entreprises du Médicament [France]
[annexe présente exemples d’actions & partenariats des Entreprises du Médicament: Novartis, sanofi-aventis, MSD (Merck Sharp & Dohme, partie de Merck), Laboratoires Pierre Fabre, Bayer, Novo Nordisk (partie de Novo Group), GlaxoSmithKline,...
- Egalement dans: Rapport de responsabilité sociale des Entreprises du Médicament - engagements dans l’accès aux soins & médicaments, l’impact environnement, dialogue avec les parties prenantes
- Entreprises concernées: Abbott Laboratories Bayer Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly GlaxoSmithKline Johnson & Johnson Merck Merck Sharp & Dohme (part of Merck) Novartis Novo Group Novo Nordisk (part of Novo Group) Pfizer Procter & Gamble Roche Sanofi-Aventis Schering-Plough Tibotec (part of Johnson & Johnson) Wyeth (part of Pfizer)
Auteur: William Baue, SocialFunds
In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) produced the most thorough study of pharmaceutical company action on HIV/AIDS, documenting how the industry falls significantly short of best practice...The Business and Human...